gastrointestinal%20stromal%20tumor
GASTROINTESTINAL STROMAL TUMOR
Gastrointestinal stromal tumors are morphologically spindle cell, epithelioid, or occasionally pleomorphic mesenchymal tumors of the gastrointestinal tract.
Signs and symptoms of gastrointestinal tumor include presence of abdominal mass (which may be an incidental finding in endoscopy), gastrointestinal bleeding, hemoperitoneum, anemia and gastrointestinal perforation.

Surgical Intervention

  • Complete surgical excision is the standard treatment of localized gastrointestinal stromal tumor (GIST)
    • Initial management of small GISTs <2 cm w/ high-risk endoscopic ultrasound (EUS) features
  • Wide local resection w/ 1- to 2-cm margin is done for most tumors
  • Tumors located in the colon may require hemicolectomy while tumors located in the rectum & anus will require abdominoperineal resection of the anus & rectum
  • Surgery may be warranted in unresectable or metastatic GIST if there is limited disease progression unresponsive to Imatinib or a locally advanced previously unresectable tumor which had a good response to Imatinib preoperatively

Preoperative Assessment

  • Computed tomography (CT) scan of the chest & abdomen should be done on all patients
    • Angiography performed if necessary (eg major vessels occluded by the tumor)
  • If large tumors are considered on the right or left upper quadrant of the abdomen, endocrine clearance should be done to exclude adrenal tumors
  • Alpha-fetoprotein (AFP) & beta-human chorionic gonadotropin (Β-hCG) levels should be determined in male patients w/ centrally placed tumors to exclude teratomas
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 6 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Percutaneous coronary intervention (PCI), compared with coronary artery bypass grafting (CABG), in the revascularization of left main coronary artery (LMCA) disease may lead to death, myocardial infarction (MI), or stroke in patients with moderate or severe left ventricular (LV) dysfunction, reveals a study.